UNC Health Medication Formulary
Add Formweb to your mobile device
System Formulary Update
Yesintek (ustekinumab-kfce) 130 mg vial and ​Yesintek (ustekinum
December 9, 2025
Situation
Yesintek (ustekinumab-kfce) 130 mg vial and 90 mg syringe were approved for addition to the UNC Health system formulary by the Executive Pharmacy and Therapeutics group in November 2025.
Background
The following medication was reviewed: Yesintek (ustekinumab-kfce)
Assessment/Recommendation
Change effective: Tuesday, December 16, 2025
- System P&T voted to include the following product on the UNC Health Medication Formulary: Yesintek (ustekinumab-kfce) ) 130 mg vial and 90 mg syringe